These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 17931824

  • 1. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ, Ngo HT, Hulse GK.
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [Abstract] [Full Text] [Related]

  • 2. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT, Tait RJ, Hulse GK.
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [Abstract] [Full Text] [Related]

  • 3. Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses.
    Arnold-Reed DE, Hulse GK, Hansson RC, Murray SD, O'Neil G, Basso MR, Holman CD.
    Addict Biol; 2003 Sep; 8(3):343-50. PubMed ID: 13129837
    [Abstract] [Full Text] [Related]

  • 4. A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users.
    Hulse GK, Tait RJ.
    Addict Biol; 2003 Sep; 8(3):337-42. PubMed ID: 13129836
    [Abstract] [Full Text] [Related]

  • 5. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT, Domingo-Salvany A, Puig R, Barrio G, García de Olalla P, de la Fuente L.
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [Abstract] [Full Text] [Related]

  • 6. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E, Shakeshaft A, Ritter A, O'Brien S, Mattick RP, NEPOD Research Group.
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [Abstract] [Full Text] [Related]

  • 7. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
    Hulse GK, Morris N, Arnold-Reed D, Tait RJ.
    Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
    [Abstract] [Full Text] [Related]

  • 8. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE, O'Neil P, Holman CD, Bulsara MK, Rodiguez C, Gawthorne G, Tait RJ, Hulse GK.
    Am J Drug Alcohol Abuse; 2007 Oct; 33(5):655-64. PubMed ID: 17891658
    [Abstract] [Full Text] [Related]

  • 9. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
    Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L.
    Drug Alcohol Depend; 2009 Nov 01; 105(1-2):9-15. PubMed ID: 19608355
    [Abstract] [Full Text] [Related]

  • 10. Mental health outcomes following naltrexone implant treatment for heroin-dependence.
    Ngo HT, Tait RJ, Arnold-Reed DE, Hulse GK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):605-12. PubMed ID: 17229510
    [Abstract] [Full Text] [Related]

  • 11. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
    Ngo HT, Tait RJ, Hulse GK.
    J Psychopharmacol; 2011 Jun 13; 25(6):774-82. PubMed ID: 20360157
    [Abstract] [Full Text] [Related]

  • 12. Favorable mortality profile of naltrexone implants for opiate addiction.
    Reece AS.
    J Addict Dis; 2010 Jan 13; 29(1):30-50. PubMed ID: 20390697
    [Abstract] [Full Text] [Related]

  • 13. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X, Khazaal Y, Besson J, Zullino DF.
    Eur Addict Res; 2007 Jan 13; 13(1):20-4. PubMed ID: 17172775
    [Abstract] [Full Text] [Related]

  • 14. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD.
    Addiction; 2005 Jun 13; 100(6):820-8. PubMed ID: 15918812
    [Abstract] [Full Text] [Related]

  • 15. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM, Grinshpoon A.
    Am J Drug Alcohol Abuse; 2007 Jun 13; 33(5):631-42. PubMed ID: 17891656
    [Abstract] [Full Text] [Related]

  • 16. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
    Davoli M, Bargagli AM, Perucci CA, Schifano P, Belleudi V, Hickman M, Salamina G, Diecidue R, Vigna-Taglianti F, Faggiano F, VEdeTTE Study Group.
    Addiction; 2007 Dec 13; 102(12):1954-9. PubMed ID: 18031430
    [Abstract] [Full Text] [Related]

  • 17. Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants.
    Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson R, O'Neil P.
    Addict Biol; 2004 Mar 13; 9(1):59-65. PubMed ID: 15203440
    [Abstract] [Full Text] [Related]

  • 18. Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
    Gibson AE, Degenhardt LJ.
    Drug Alcohol Rev; 2007 Jul 13; 26(4):405-10. PubMed ID: 17564876
    [Abstract] [Full Text] [Related]

  • 19. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
    Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson RC.
    Addict Biol; 2004 Mar 13; 9(1):67-72. PubMed ID: 15203441
    [Abstract] [Full Text] [Related]

  • 20. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings.
    Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I.
    Addiction; 2007 Mar 13; 102(3):406-12. PubMed ID: 17298648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.